Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Published:2016-12-05 Issue:2 Volume:35 Page:180-188
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Beg Muhammad S.,Brenner Andrew J.,Sachdev Jasgit,Borad Mitesh,Kang Yoon-Koo,Stoudemire Jay,Smith Susan,Bader Andreas G.,Kim Sinil,Hong David S.

Funder

Mirna Therapeutics Inc

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-016-0407-y.pdf

Reference41 articles.

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297

2. Londin E, Loher P, Telonis AG et al (2015) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. PNAS 23:E1106–E1115Epub February

3. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233

4. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866

5. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259–269

Cited by 666 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the development and clinical application of miRNAs in infectious diseases;Non-coding RNA Research;2025-02

2. The role of MiRNA-34 family in different signaling pathways and its therapeutic options;Gene;2024-12

3. Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia;Cureus;2024-09-06

4. MicroRNAs: emerging biomarkers and therapeutic targets in pancreatic cancer;Frontiers in Molecular Biosciences;2024-09-03

5. Beyond the Beat: Understanding Inherited Risk and Therapeutic Opportunities in Cardiovascular Diseases with Emphasis on Inherited Cardiomyopathies and Inherited Arrhythmic Syndromes;Cardiogenetics;2024-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3